Quantification of Task-Specific Glucose Metabolism with Constant Infusion of 18F-FDG

The investigation of cerebral metabolic rate of glucose (CMRGlu) at baseline and during specific tasks previously required separate scans with the drawback of high intrasubject variability. We aimed to validate a novel approach to assessing baseline glucose metabolism and task-specific changes in a single measurement with a constant infusion of 18F-FDG. Methods: Fifteen healthy subjects underwent two PET measurements with arterial blood sampling. As a reference, baseline CMRGlu was quantified from a 60-min scan after 18F-FDG bolus application using the Patlak plot (eyes closed). For the other scan, a constant radioligand infusion was applied for 95 min, during which the subjects opened their eyes at 10–20 min and 60–70 min and tapped their right thumb to their fingers at 35–45 min and 85–95 min. The constant-infusion scan was quantified in two steps. First, the general linear model was used to fit regional time–activity curves with regressors for baseline metabolism, task-specific changes for the eyes-open and finger-tapping conditions, and movement parameters. Second, the Patlak plot was used for quantification of CMRGlu. Multiplication of the baseline regressor by β-values from the general linear model yielded regionally specific time–activity curves for baseline metabolism. Further, task-specific changes in metabolism are directly proportional to changes in the slope of the time–activity curve and hence to changes in CMRGlu. Results: Baseline CMRGlu from the constant-infusion scan matched that from the bolus application (test–retest variability, 1.1% ± 24.7%), which was not the case for a previously suggested approach (variability, −39.9% ± 25.2%, P < 0.001). Task-specific CMRGlu increased in the primary visual and motor cortices for eyes open and finger tapping, respectively (P < 0.05, familywise error–corrected), with absolute changes of up to 2.1 μmol/100 g/min and 6.3% relative to baseline. For eyes open, a decreased CMRGlu was observed in default-mode regions (P < 0.05, familywise error–corrected). CMRGlu quantified with venous blood samples (n = 6) showed excellent agreement with results obtained from arterial samples (r > 0.99). Conclusion: Baseline glucose metabolism and task-specific changes can be quantified in a single measurement with constant infusion of 18F-FDG and venous blood sampling. The high sensitivity and regional specificity of the approach offer novel possibilities for functional and multimodal brain imaging.

[1]  Joel S. Karp,et al.  Concurrent CBF and CMRGlc changes during human brain activation by combined fMRI–PET scanning , 2005, NeuroImage.

[2]  G L Shulman,et al.  INAUGURAL ARTICLE by a Recently Elected Academy Member:A default mode of brain function , 2001 .

[3]  S. Larson,et al.  Test-retest studies of cerebral glucose metabolism using fluorine-18 deoxyglucose: validation of method. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[4]  Suzanne T. Witt,et al.  Functional neuroimaging correlates of finger-tapping task variations: An ALE meta-analysis , 2008, NeuroImage.

[5]  K. Hamacher,et al.  Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  F. Schick,et al.  Simultaneous PET-MRI reveals brain function in activated and resting state on metabolic, hemodynamic and multiple temporal scales , 2013, Nature Medicine.

[7]  M. Ginsberg,et al.  Two behavioral states studied in a single PET/FDG procedure: error analysis. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  Karl J. Friston,et al.  Unified segmentation , 2005, NeuroImage.

[9]  M Corbetta,et al.  Searching for activations that generalize over tasks , 1997, Human brain mapping.

[10]  M. Ernst,et al.  Cerebral glucose metabolism during pharmacologic studies: test-retest under placebo conditions. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[11]  R. V. Van Heertum,et al.  Pittsburgh Compound B (11C-PIB) and Fluorodeoxyglucose (18 F-FDG) PET in Patients With Alzheimer Disease, Mild Cognitive Impairment, and Healthy Controls , 2010, Journal of geriatric psychiatry and neurology.

[12]  Robert M. Kessler,et al.  Imaging methods for evaluating brain function in man , 2003, Neurobiology of Aging.

[13]  J L McGaugh,et al.  Amygdala activity at encoding correlated with long-term, free recall of emotional information. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Juha Salmi,et al.  Orienting and maintenance of spatial attention in audition and vision: multimodal and modality-specific brain activations , 2007, Brain Structure and Function.

[15]  J. Logan Graphical analysis of PET data applied to reversible and irreversible tracers. , 1999, Nuclear medicine and biology.

[16]  G. Kranz,et al.  High-resolution functional MRI of the human amygdala at 7 T , 2013, European journal of radiology.

[17]  R. Haier,et al.  Individual differences in general intelligence correlate with brain function during nonreasoning tasks , 2003 .

[18]  Christian Windischberger,et al.  Toward discovery science of human brain function , 2010, Proceedings of the National Academy of Sciences.

[19]  Thomas K Lewellen,et al.  The FDG lumped constant in normal human brain. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  Bruce R. Rosen,et al.  Dynamic functional imaging of brain glucose utilization using fPET-FDG , 2014, NeuroImage.

[21]  J. Mazziotta,et al.  METABOLIC MAPPING OF THE BRAIN'S RESPONSE TO VISUAL STIMULATION: STUDIES IN HUMANS , 1981, Science.

[22]  Henry Rusinek,et al.  Quantitation, regional vulnerability, and kinetic modeling of brain glucose metabolism in mild Alzheimer’s disease , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[23]  Wolfgang Birkfellner,et al.  Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial sampling , 2012, NeuroImage.

[24]  D. Feng,et al.  Noninvasive Quantification of the Cerebral Metabolic Rate for Glucose Using Positron Emission Tomography, 18F-Fluoro-2-Deoxyglucose, the Patlak Method, and an Image-Derived Input Function , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[25]  Y Imahori,et al.  Simplification for measuring input function of FDG PET: investigation of 1-point blood sampling method. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  Hiroshi Fukuda,et al.  Functional brain mapping of actual car-driving using [18F]FDG-PET , 2006, Annals of nuclear medicine.

[27]  Mark A. Mintun,et al.  Human brain glucose metabolism may evolve during activation: Findings from a modified FDG PET paradigm , 2006, NeuroImage.

[28]  C. Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations , 1985, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[29]  Pia Baldinger,et al.  Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression , 2014, Human brain mapping.

[30]  A. Franco,et al.  Toward a neuroimaging treatment selection biomarker for major depressive disorder. , 2013, JAMA psychiatry.

[31]  Klaus Wienhard,et al.  Measurement of glucose consumption using [(18)F]fluorodeoxyglucose. , 2002, Methods.

[32]  Frederik Barkhof,et al.  Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[33]  J. Konishi,et al.  Double-injection FDG method to measure cerebral glucose metabolism twice in a single procedure , 2001, Annals of nuclear medicine.

[34]  Alan C. Evans,et al.  Mapping of change in cerebral glucose utilization using fluorine-18 fluorodeoxyglucose double injection and the constrained weighted-integration method , 1996, IEEE Trans. Medical Imaging.

[35]  Wesley T. Kerr,et al.  Computer-Aided Diagnosis and Localization of Lateralized Temporal Lobe Epilepsy Using Interictal FDG-PET , 2013, Front. Neurol..

[36]  Jeremy D. Schmahmann,et al.  Functional topography of the cerebellum for motor and cognitive tasks: An fMRI study , 2012, NeuroImage.

[37]  Philippe A. Chouinard,et al.  Overlapping neural circuits for visual attention and eye movements in the human cerebellum , 2015, Neuropsychologia.

[38]  Esin Cakan,et al.  The use of 18F-FDG PET ratios in the differential diagnosis of common malignant brain tumors. , 2015, Clinical imaging.

[39]  W. Wadsak,et al.  Basics and principles of radiopharmaceuticals for PET/CT. , 2010, European journal of radiology.

[40]  Karl J. Friston,et al.  Local Activity Determines Functional Connectivity in the Resting Human Brain: A Simultaneous FDG-PET/fMRI Study , 2014, The Journal of Neuroscience.

[41]  Russell A. Poldrack,et al.  Handbook of Functional MRI Data Analysis: Visualizing, localizing, and reporting fMRI data , 2011 .